Asset vs asset
LEO Token is a exchange-linked market proxy with $8.76B in market cap, while Injective is a INJ market beta asset with $303.19M. The useful comparison is market role, liquidity, seven-day direction, and which follow-up page gives the cleaner next decision.
Comparison Table
| Question | LEO Token | Injective |
|---|---|---|
| Market role | exchange-linked market proxy | INJ market beta asset |
| Price | $9.52 | $3.03 |
| Market cap | $8.76B | $303.19M |
| 24h volume | $410,777.00 | $38.31M |
| 7d change | +3.66% | -1.11% |
| Relative size | LEO Token is 28.90x Injective's market cap | Injective is 0.03x LEO Token's market cap |
| Volume comparison | LEO Token trades at 0.01x Injective's 24h volume | Injective trades at 93.27x LEO Token's 24h volume |
Use the market-cap calculator when the real question is what one asset would imply at another size.
Open calculatorA cleaner comparison still needs a practical plan for exchanges, withdrawals, and wallets.
Open checklistPut both names back into the wider market context before treating the comparison as a final answer.
Open markets